131 related articles for article (PubMed ID: 37433350)
1. Enhancement in the therapeutic potential of lapatinib ditosylate against breast cancer by the use of β-cyclodextrin based ternary nanosponge system.
Tanaji Mane P; Sopanrao Wakure B; Shridhar Wakte P
Int J Pharm; 2023 Jul; 642():123210. PubMed ID: 37433350
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of exemestane into ternary nanosponge system for enhanced anti-tumor potential in breast cancer.
Mane PT; Wakure BS; Wakte PS
Pharm Dev Technol; 2023 Dec; 28(10):1000-1015. PubMed ID: 37961995
[TBL] [Abstract][Full Text] [Related]
3. Solubility and dissolution rate enhancement of ibuprofen by cyclodextrin based carbonate nanosponges.
Shoaib QU; Latif S; Ijaz QA; Afzal H; Siddique MI; Hussain A; Arshad MS; Bukhari NI; Abbas N
Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1045-1055. PubMed ID: 34602431
[TBL] [Abstract][Full Text] [Related]
4. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
5. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W
J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
7. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J
J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation
Zainuddin R; Zaheer Z; Sangshetti JN; Momin M
Drug Dev Ind Pharm; 2017 Dec; 43(12):2076-2084. PubMed ID: 28845699
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
10. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
Sherje A; Londhe V
Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
[TBL] [Abstract][Full Text] [Related]
11. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation.
Mashaqbeh H; Obaidat R; Al-Shar'i N
Polymers (Basel); 2021 Nov; 13(23):. PubMed ID: 34883577
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of Bioavailability of Non-nucleoside Reverse Transciptase Inhibitor Using Nanosponges.
Rao MRP; Shirsath C
AAPS PharmSciTech; 2017 Jul; 18(5):1728-1738. PubMed ID: 27757921
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine.
Awais S; Farooq N; Muhammad SA; El-Serehy HA; Ishtiaq F; Afridi M; Ahsan H; Ullah A; Nadeem T; Sultana K
Molecules; 2023 May; 28(9):. PubMed ID: 37175270
[TBL] [Abstract][Full Text] [Related]
15. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of Piroxicam nanosponge for improved internal solubility and analgesic activity.
Gaber DA; Radwan MA; Alzughaibi DA; Alail JA; Aljumah RS; Aloqla RM; Alkhalifah SA; Abdoun SA
Drug Deliv; 2023 Dec; 30(1):2174208. PubMed ID: 36744372
[TBL] [Abstract][Full Text] [Related]
17. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
Semalty M; Panchpuri M; Singh D; Semalty A
Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
[TBL] [Abstract][Full Text] [Related]
19. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability.
Dora CP; Trotta F; Kushwah V; Devasari N; Singh C; Suresh S; Jain S
Carbohydr Polym; 2016 Feb; 137():339-349. PubMed ID: 26686138
[TBL] [Abstract][Full Text] [Related]
20. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
Bhargava S; Agrawal GP
Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
